Related references
Note: Only part of the references are listed.Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease
Tomotaka Tanaka et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Shorena Janelidze et al.
NATURE MEDICINE (2020)
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling data from four cohorts
Thomas K. Karikari et al.
LANCET NEUROLOGY (2020)
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
Axel Montagne et al.
NATURE (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
Alberto Benussi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected
Marc Suarez-Calvet et al.
EMBO MOLECULAR MEDICINE (2020)
Prevalence and clinical relevance of diffusion-weighted imaging lesions The Rotterdam study
Saima Hilal et al.
NEUROLOGY (2019)
Multicollinearity and misleading statistical results
Jong Hae Kim
KOREAN JOURNAL OF ANESTHESIOLOGY (2019)
Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
Zhuohao He et al.
NATURE MEDICINE (2018)
Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Update on biomarkers for amyloid pathology in Alzheimer's disease
Nicholas J. Ashton et al.
BIOMARKERS IN MEDICINE (2018)
Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease
Che-Chuan Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
Taeko Kimura et al.
FRONTIERS IN NEUROSCIENCE (2018)
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
Inge M. W. Verberk et al.
ANNALS OF NEUROLOGY (2018)
Current state of Alzheimer's fluid biomarkers
Jose Luis Molinuevo et al.
ACTA NEUROPATHOLOGICA (2018)
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2018)
Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) multicenter study
Tomohiko Yamane et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome
Harutsugu Tatebe et al.
MOLECULAR NEURODEGENERATION (2017)
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod et al.
ALZHEIMERS & DEMENTIA (2017)
Post-mortem assessment in vascular dementia: advances and aspirations
Kirsty E. McAleese et al.
BMC MEDICINE (2016)
Alzheimer's disease with cerebrovascular disease: current status in the Asia-Pacific region
C. Chen et al.
JOURNAL OF INTERNAL MEDICINE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients
Shashank Shekhar et al.
PLOS ONE (2016)
Plasma β-amyloid in Alzheimer's disease and vascular disease
Shorena Janelidze et al.
SCIENTIFIC REPORTS (2016)
Alzheimer's Association Report 2015 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2015)
Markers of Cardiac Dysfunction in Cognitive Impairment and Dementia
Saima Hilal et al.
MEDICINE (2015)
Cerebrovascular Pathology and Amyloid Plaque Formation in Alzheimer's Disease
Chu-Wan Lee et al.
CURRENT ALZHEIMER RESEARCH (2014)
Novel plasma biomarker surrogating cerebral amyloid deposition
Naoki Kaneko et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2014)
Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases
Valeriy Duka et al.
PLOS ONE (2013)
Plasma tau levels in Alzheimer's disease
Henrik Zetterberg et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Accuracy and reproducibility study of automatic MRI brain tissue segmentation methods
Renske de Boer et al.
NEUROIMAGE (2010)
Cognitive Decline and Dementia Related to Cerebrovascular Diseases: Some Evidence and Concepts
Leonardo Pantoni et al.
CEREBROVASCULAR DISEASES (2009)
Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
E. Hellstrom-Lindahl et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification
Henri A. Vrooman et al.
NEUROIMAGE (2007)
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease
Steven Ng et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Distinct early folding and aggregation properties of Alzheimer amyloid-β peptides Aβ40 and Aβ42 -: Stable trimer or tetramer formation by Aβ42
Yun-Ru Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function
DA Bennett et al.
ARCHIVES OF NEUROLOGY (2004)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Alzheimer disease and cerebrovascular pathology: an update
KA Jellinger
JOURNAL OF NEURAL TRANSMISSION (2002)
Share Paper
